NHSxx

Market Access

The UK-US drug pricing deal: A welcome step, but not the fin...

The UK-US deal eases medicines pricing uncertainty, lifts NICE threshold, and boosts confidence, but UK pharma still needs pricing reform

Sales & Marketing

Solution Spotlight: IQVIA Market Access Launch Pad

IQVIA Market Access Launch Pad is a dynamic and comprehensive suite of tools designed to support pharmaceutical companies in their product launch readiness.

Digital

We can’t fix modern healthcare with 1950s solutions. AI is t...

In today’s NHS, the urgency of embracing artificial intelligence (AI) is no longer a matter of innovation - it’s a matter of survival.

News

UK trials will put dementia blood tests through their paces

Researchers in the UK will soon start trialling blood tests that promise to diagnose dementia at clinics across the country in the hope of having them in rout

News

NICE backs use of post-stroke genetic testing

NICE has launched a new consultation on the use of CYP2C19 genotype testing to guide treatment after a stroke or transient ischaemic attack (TIA) or ‘mini-stroke’.

News

NICE endorses use of digital therapies for psychosis

Three digital health technologies (DHTs) used to support patients with psychosis can be used by the NHS while additional evidence of their benefits is gathered.

The UK-US drug pricing deal: A welcome step, but not the fin...

Solution Spotlight: IQVIA Market Access Launch Pad

We can’t fix modern healthcare with 1950s solutions. AI is t...

UK trials will put dementia blood tests through their paces

NICE backs use of post-stroke genetic testing

NICE endorses use of digital therapies for psychosis

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

NHSxx

Editor's Picks